Physicians managing chronic migraine may be interested in new comparative patient-reported data from the FORWARD study, which evaluated treatment satisfaction with onabotulinumtoxinA versus topiramate. In...
At the 2026 American Academy of Neurology Annual Meeting in Chicago, IL, investigators presented real-world evidence evaluating whether glucagon-like peptide-1 receptor agonists influence healthcare...
In this session, Maureen Moriarty, DNP, ANP-BC, talked about the epidemiology of migraine, the effects of different dietary patters on migraine symptoms, and the role vitamins and supplements play.
